Thursday, April 30, 2026

How Apple’s Siri Will Transform with Google’s Gemini AI: A Game-Changer for 2026

Apple aims to enhance Siri with Google's Gemini AI, improving connectivity and user interaction through an upcoming iOS update.

North Korean Troops in Russia’s Underground Tunnel Construction

There are speculations that North Korean soldiers will be mobilized for Russia's tunnel construction for the attack on Ukraine.

“Fleeing the Front Line”: PPP Leader Abandons Seoul for D.C. as “Election War” Looms

Han Dong-hyuk's early U.S. trip aims to strengthen U.S.-Korea ties and address economic issues ahead of local elections.

Jin Joong Hwang

Author's Latest

LG’s AI Revolution: How Collaboration with Palantir and SkilledAI Will Transform the Future of Robotics

LG Group's chairman met with AI leaders in Silicon Valley to explore collaboration and enhance AI commercialization in manufacturing.

Revolutionizing Work: How HSAD’s Deep Agent Builder Empowers AI-Driven Marketing in 2026

HSAD's Agent Builder Day showcased AI agent creation, enhancing workflows and marketing capabilities through user-friendly natural language inputs.

Revolutionizing Work: How HSAD’s Deep Agent Builder Empowers AI-Driven Marketing in 2026

HSAD's Agent Builder Day showcased AI agents created by employees, enhancing workflows and marketing capabilities through natural language inputs.

Hanwha Vision’s Next-Gen AI Hybrid Security Solution BLAZE Unveiled at ISC WEST 2026

Hanwha Vision showcased its AI video surveillance solution BLAZE at ISC WEST 2026, highlighting innovative features for enhanced security.

Your Ultimate Guide to the 2026 LG OLED Evo: Brightness, AI Features, and Pricing Revealed!

LG Electronics unveils its 2026 OLED TV with advanced AI, ultra-low reflection, and enhanced brightness for superior viewing experiences.

Digital Health Week 2026: How Daewoong Pharmaceutical is Revolutionizing Healthcare with 8 Innovative Products

Daewoong Pharmaceutical's Digital Health Week 2026 showcased digital healthcare innovations to 39,753 professionals, highlighting real-world applications.

Lotte Biologics at DCAT Week 2026: Unveiling Strategic Collaborations in Global CDMO

Lotte Biologics will attend DCAT Week in New York to pursue global CDMO partnerships and showcase its production capabilities.

Samsung Biologics CEO John Rim Poised for Third Term: What This Means for the Global CDMO Market in 2026

John Rim of Samsung Biologics aims for a third term, leading record growth and expansion into next-gen therapies amid global challenges.

Dongkoo Bio&Pharma Invests 1 Billion KRW in GenomAndCompany: What This Means for ADC Drug Development

Dongkoo Bio&Pharma invests 1 billion KRW in Genome & Company to enhance antibody and ADC drug development strategies.

Celltrion’s Ramucirumab and Infliximab: The Secrets Behind Their Dominance in Oceania’s Biopharmaceutical Market

Celltrion's cancer and autoimmune products are expanding market share in Australia and New Zealand, enhancing influence in Oceania.

How Celltrion’s Herceptin Biosimilar Herzuma Achieved 74% Market Share in Japan: A Game Changer for Cancer Treatment

Celltrion's Herzuma biosimilar captures 74% of Japan's trastuzumab market, enhancing patient access and leveraging favorable policies.

New Research Security Law: How Korea is Protecting Scientists from Global Threats

Rep. Choi Soo-jin emphasizes the need for a robust research security system to protect against foreign recruitment and technology theft.

CGBio’s NovoFactory: A Game-Changer for Bone Graft Products in the U.S. and Japan

CGBio's new Novo Factory in Hwaseong receives approval to produce Novosis Putty, targeting advanced markets like the U.S. and Japan.

SK Plasma’s Historic 65 Million EUR Tech Export Deal: What It Means for Turkey’s Pharmaceutical Independence

SK Plasma signs a €65M tech transfer deal with Turkey to boost local production of essential medicines, enhancing global healthcare access.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.